Cognex Corp. (CGNX) financials: revenue, earnings and cash flow
Fiscal 2016–2025 + TTM · from SEC filings · data as of November 13, 2026
Summary
Cognex’s revenue went from $530M in fiscal 2016 to $994M in fiscal 2025, growth of about 7.3% a year.
Net income in fiscal 2025 was $114M, a net margin of 11.5%; the best year in this period was 2021 with $280M.
Over the twelve months to October 4, 2026, revenue was $1.1B and net income $242M.
Free cash flow was $237M in fiscal 2025 and positive in 10 of the 10 years shown.
The diluted share count fell 3% over the period (buybacks).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.1B | $994M | $915M | $838M | $1.0B | $1.0B | $811M | $726M | $806M | $766M | $530M |
| Gross profit | $784M | $665M | $626M | $601M | $722M | $760M | $605M | $536M | $600M | $579M | $398M |
| Operating income | $281M | $163M | $115M | $131M | $246M | $315M | $171M | $143M | $221M | $259M | $154M |
| Net income | $242M | $114M | $106M | $113M | $216M | $280M | $176M | $204M | $219M | $177M | $144M |
| EPS (diluted) | $1.44 | $0.68 | $0.62 | $0.65 | $1.23 | $1.56 | $1.00 | $1.16 | $1.24 | $0.98 | $0.83 |
| R&D | $139M | $139M | $140M | $139M | $141M | $135M | $131M | $119M | $116M | $99M | $78M |
| Revenue growth | — | +8.7% | +9.2% | −16.8% | −3.0% | +27.9% | +11.8% | −10.0% | +5.2% | +44.7% | +17.5% |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $296M | $246M | $149M | $113M | $243M | $314M | $242M | $253M | $223M | $224M | $182M |
| Capital spending | -$10M | -$9M | -$15M | -$23M | -$20M | -$15M | -$13M | -$22M | -$37M | -$29M | -$13M |
| Free cash flow | $286M | $237M | $134M | $90M | $224M | $299M | $229M | $232M | $186M | $196M | $169M |
| Dividends paid | $57M | $55M | $52M | $49M | $46M | $43M | $391M | $35M | $32M | $29M | $25M |
| Buybacks | $130M | $151M | $67M | $80M | $204M | $162M | $51M | $62M | $204M | $124M | $47M |
| Stock-based pay | $48M | $49M | $52M | $55M | $55M | $44M | $1M | $46M | $41M | $32M | $21M |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | — | $337M | $246M | $332M | $400M | $324M | $372M | $412M | $536M | $405M | $421M |
| Debt | — | $77M | $70M | $79M | $40M | $26M | $26M | $18M | $0 | $0 | $0 |
| Equity | — | $1.5B | $1.5B | $1.5B | $1.4B | $1.4B | $1.3B | $1.4B | $1.1B | $1.1B | $963M |
| Total assets | — | $2.0B | $2.0B | $2.0B | $2.0B | $2.0B | $1.8B | $1.9B | $1.3B | $1.3B | $1.0B |
| Shares (diluted) | 171M | 169M | 173M | 173M | 175M | 180M | 177M | 175M | 177M | 180M | 174M |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 69.7% | 66.9% | 68.4% | 71.8% | 71.8% | 73.3% | 74.6% | 73.9% | 74.5% | 75.5% | 75.2% |
| Operating margin | 25.0% | 16.4% | 12.6% | 15.6% | 24.5% | 30.4% | 21.0% | 19.7% | 27.4% | 33.8% | 29.1% |
| Net margin | 21.5% | 11.5% | 11.6% | 13.5% | 21.4% | 27.0% | 21.7% | 28.1% | 27.2% | 23.1% | 27.1% |
| FCF margin | 25.4% | 23.8% | 14.7% | 10.7% | 22.2% | 28.8% | 28.2% | 31.9% | 23.1% | 25.5% | 32.0% |
| ROIC | — | 6.5% | 5.9% | 6.9% | 14.3% | 19.0% | 12.5% | 8.2% | 18.2% | 15.7% | 14.2% |
| ROE | — | 7.7% | 7.0% | 7.5% | 15.0% | 19.6% | 14.0% | 15.0% | 19.3% | 16.1% | 14.9% |
Frequently asked questions
What is Cognex’s annual revenue?
$994M in fiscal 2025 and $1.1B over the twelve months to October 4, 2026.
How much profit does Cognex make?
Net income was $114M in fiscal 2025 (net margin 11.5%).
Is Cognex’s revenue growing?
Yes: revenue rose 8.7% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.